Want to join the conversation?
Michael Nannizzi of Goldman Sachs asks if $WRB expects a natural expense ratio for the businesses it is starting to be different than the remainder of its business. CEO Robert Berkley said some of the businesses will take more time to mature than others and added $WRB expects the ratio to be in the low-30s long term and expects to push it farther.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?